Why US Manufacturers Need ISO 13485
For US medical device manufacturers, the domestic market operates primarily under the FDA's regulatory framework, including 21 CFR Part 820 (Quality System Regulation). While this framework has served the US market well, expanding into international markets — particularly the European Union — requires demonstrating compliance with additional standards. ISO 13485:2016 is the globally recognized quality management standard for the medical device industry and is the foundation for EU market access.
ISO 13485 certification is not merely a regulatory checkbox — it represents a commitment to systematic quality management that benefits the entire organization. US manufacturers who achieve ISO 13485 certification gain a competitive advantage in both domestic and international markets.
Benefits of ISO 13485 for US Companies
- EU Market Access: ISO 13485 certification is a prerequisite for the MDR conformity assessment process. Without a certified QMS, manufacturers cannot obtain CE marking for their devices.
- Regulatory Harmonization: ISO 13485 aligns with multiple international regulatory frameworks, enabling manufacturers to leverage a single QMS to satisfy requirements in the EU, Canada, Japan, Australia, and other markets.
- FDA Alignment: The FDA recognizes ISO 13485 and has been working to harmonize 21 CFR Part 820 with the international standard. Manufacturers who maintain ISO 13485 compliance are well-positioned for any future FDA updates.
- MDSAP Compatibility: The Medical Device Single Audit Program (MDSAP) allows a single audit to cover multiple regulatory jurisdictions, including the US, EU, Canada, Japan, Australia, and Brazil. ISO 13485 forms the audit model for MDSAP.
- Operational Improvement: Implementing ISO 13485 drives process consistency, improved risk management, better supplier control, and more effective corrective and preventive actions.
- Customer and Partner Confidence: Many OEMs, distributors, and healthcare organizations require their medical device suppliers to hold ISO 13485 certification.
ISO 13485 vs. 21 CFR Part 820
US manufacturers who already comply with FDA 21 CFR Part 820 will find significant overlap with ISO 13485:2016. However, important differences exist that must be addressed:
- Risk Management Integration: ISO 13485 requires risk management to be applied throughout the QMS and product lifecycle, with explicit references to risk-based decision making. While 21 CFR Part 820 requires risk analysis, ISO 13485 takes a more integrated approach.
- Documentation Requirements: ISO 13485 has specific requirements for a quality manual, which is not explicitly required under 21 CFR Part 820. The standard also requires documented procedures for medical device file management and regulatory reporting.
- Software Validation: Both frameworks require software validation, but ISO 13485 includes specific requirements (Clause 7.3.3, 7.5.6) for software used in production and QMS processes, as well as software that is itself a medical device.
- Post-Market Obligations: ISO 13485 includes requirements for feedback, complaint handling, and reporting to regulatory authorities. The EU MDR imposes additional post-market surveillance requirements beyond those in 21 CFR Part 820.
- Design Transfer: ISO 13485 explicitly addresses design and development transfer (Clause 7.3.8), ensuring that design outputs are verified for manufacturing suitability before production begins.
The Path to ISO 13485 Certification for US Companies
- Gap Assessment: Conduct an internal assessment comparing your current QMS (typically 21 CFR Part 820 based) against the ISO 13485:2016 requirements. Identify areas where your system needs enhancement or additional documentation.
- QMS Enhancement: Address the gaps identified in the assessment. Common areas for US manufacturers include developing a quality manual, enhancing risk management integration, establishing a medical device file structure, and updating documentation to meet ISO 13485 terminology and structure.
- Internal Audit and Management Review: Conduct a thorough internal audit of the updated QMS and perform a management review to verify the system's suitability and effectiveness before engaging the certification body.
- Certification Application: Apply to Udem Atlantic for ISO 13485 certification. Our team will review your application, confirm the audit scope, and schedule the certification audit.
- Stage 1 and Stage 2 Audits: Udem Atlantic conducts the two-stage certification audit at your US facility. Our auditors are experienced with US manufacturing environments and understand the FDA regulatory context.
- Certification and Ongoing Compliance: Upon successful completion, Udem Atlantic issues the ISO 13485:2016 certificate. Annual surveillance audits ensure continued compliance throughout the three-year certification cycle.
EU Market Entry for US Manufacturers
ISO 13485 certification is one component of the broader EU market access strategy for US manufacturers. To place medical devices on the EU market, manufacturers must also:
- Appoint an EU Authorized Representative
- Complete the applicable MDR conformity assessment with a Notified Body
- Prepare technical documentation per MDR Annex II and III
- Obtain a CE certificate and affix the CE mark
- Register devices in EUDAMED and implement UDI requirements
- Establish post-market surveillance and vigilance systems
Udem Atlantic can support US manufacturers through both ISO 13485 certification and the MDR conformity assessment process, providing a streamlined path to EU market access.
For more information about the differences between EU and US regulatory frameworks, see our CE Marking vs FDA Approval comparison.
Request a quote to discuss your ISO 13485 certification needs, or contact our team to learn more about our services for US manufacturers.